Shares of MedPlus Health Services fell sharply on Tuesday, declining 15.83% to Rs 667.95 after the company reported a weaker-than-expected performance in the first quarter of FY27.
The decline came as investors reacted to pressure on profitability, with a contraction in gross margins and higher operating expenses offsetting healthy revenue growth. Despite the weak quarterly performance, brokerage Nomura maintained its Buy rating on the stock, citing the company’s long-term growth potential and store expansion strategy.
